Topic: SARS-Cov-2 virus
UK :1st country to approve Omicron Vaccine
The United Kingdom has authorized the first ever covid-19 vaccine for Omicron variant. It is the first country to do so. Authorization of vaccine will now pave ways...
IISc-CSIR Research to inactivate SARS-CoV-2
Researchers from Indian Institute of Science (IISc) recently conducted an experiment to inactivate the SARS-CoV-2 virus, in collaboration with the CSIR-Institute of Microbial Technology. Key Facts Researchers found...
What is ‘TriSb92’ Molecule?
Researchers from University of Helsinki have developed a molecule, that can inactivate the coronavirus spike protein. It also offers effective short-term protection against the coronavirus. About TriSb92 Molecule...
NeoCov Coronavirus
According to Chinese researchers, a type of coronavirus called NeoCov, which spreads among bats in South Africa is likely to pose threat to humans if it mutates further, in...
IIT-D develops test to detect Omicron in 90 min
Researchers from IIT Delhi’s Kusuma School of Biological Sciences have developed an RT-PCR based test, that can detect Omicron variant of SARS-CoV-2 in 90 minutes. Key Points The... WHO: Omicron Poses Very High Global Risk
On November 29, 2021, World Health Organization (WHO) warned that; the new variant of SARS-CoV-2 virus called “Omicron” poses very high global risk. Highlights Early evidence shows that,... WHO: SARS-CoV-2 variant B.1.1.529 a ‘Variant of Concern’
The World Health Organisation (WHO) designated SARS-CoV-2 variant B.1.1529 as a ‘variant of concern’. Key Points This variant of SARS-CoV-2 has been named as Omicron. This variant was first...
Study: White-tailed deer being infected with SARS-CoV-2
A new study from US shows that white-tailed deer are being infected with SARS-CoV-2, the virus causing COVID-19 in humans. Key Points During the study, Antibodies were found in 40% of deer....
Covaxin approved for emergency use in 2–18-year-olds
The Subject Expert Committee on Covid-19 has approved the “emergency use” of Bharat Biotech’s Covaxin vaccine for children aged between 2-18 years old. Key Points Phase-2 and Phase-3... EU approves Pfizer-BioNTech COVID vaccine booster
European Medicines Agency (EMA) approved the booster doses of Pfizer/BioNTech Covid-19 vaccine for people aged 18 and above on October 4, 2021. Key Facts This approval given as...
WHO Chief Scientist: Covid vaccination is not absolute protection
Chief scientist of World Health Organisation (WHO), Dr. Soumya Swaminathan, noted that though Covid-19 vaccines may not provide absolute protection against emerging variants of the coronavirus. However, it... 